Merck expands drug plant

JAKARTA: Publicly listed drug company PT Merck Indonesia Tbk, a subsidiary of German firm Merck KGaA, has expanded its production facilities in Pasar Rebo, Jakarta, to strengthen its position in the Indonesian market.

The expansion project, which started in 2001 and was recently completed, absorbed a total investment of Rp 40 billion (US$4.7 million), the company said in a statement on Tuesday.

"This is a clear evidence of Merck's determination to continue its presence in Indonesia," president director Rudolf G. Stock said.

Globally and in Indonesia, Merck is well known for its diabetes and cardiovascular drugs. Its popular drugs include Concor and Glocophage which are used to treat diabetes and cardiovascular complaints respectively.

Aside from the above drugs, the firm also produces popular health care products, such as Neurobion, Sangobion and Evion. -- JP